Related references
Note: Only part of the references are listed.Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Naveen S. Vasudev et al.
ANGIOGENESIS (2014)
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway
Jing-Tao Zhang et al.
BMC CANCER (2014)
Inhibition of Tumor Vasculogenic Mimicry and Prolongation of Host Survival in Highly Aggressive Gallbladder Cancers by Norcantharidin via Blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin Signaling Pathway
Hui Wang et al.
PLOS ONE (2014)
Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways
Long Zhang et al.
CANCER SCIENCE (2013)
New Model of In-situ Xenograft Lymphangiogenesis by a Human Colonic Adenocarcinoma Cell Line in Nude Mice
Jian-Jun Sun et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Combining Antiangiogenics to Overcome Resistance: Rationale and Clinical Experience
Victor Moreno Garcia et al.
CLINICAL CANCER RESEARCH (2012)
Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development
G. Ranieri et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
Wolfgang Sieghart et al.
EUROPEAN RADIOLOGY (2012)
Sorafenib for the treatment of renal cancer
Dirk Strumberg
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature
Jun Wang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Rapamycin Inhibits Lymphatic Endothelial Cell Tube Formation by Downregulating Vascular Endothelial Growth Factor Receptor 3 Protein Expression
Yan Luo et al.
NEOPLASIA (2012)
Nuclear translocation of phosphorylated STAT3 regulates VEGF-A-induced lymphatic endothelial cell migration and tube formation
Hideki Okazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Sorafenib Enhances the Antitumor Effects of Chemoradiation Treatment by Downregulating ERCC-1 and XRCC-1 DNA Repair Proteins
Arti Yadav et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Silencing Id-1 inhibits lymphangiogenesis through down-regulation of VEGF-C in oral squamous cell carcinoma
Zuoqing Dong et al.
ORAL ONCOLOGY (2011)
Endostar, a Recombined Humanized Endostatin, Inhibits Lymphangiogenesis and Lymphatic Metastasis of Lewis Lung Carcinoma Xenograft in Mice
X. Dong et al.
THORACIC AND CARDIOVASCULAR SURGEON (2011)
Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis
Xiao-Mei Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Targeting Tumor Lymphangiogenesis: An Update
M. Raica et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Deguelin-an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model
Jia Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Lymphangiogenesis: A new player in cancer progression
Masayuki Nagahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Lentivirus-Mediated Small Interfering RNA Targeting VEGF-C Inhibited Tumor Lymphangiogenesis and Growth in Breast Carcinoma
Baoliang Guo et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via VEGF-C
Huidong Liu et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Marja Lohela et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model
Jing Wen et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Tumor metastasis and the lymphatic vasculature
Jonathan P. Sleeman et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect
Yu-Jen Chen et al.
LIFE SCIENCES (2009)
VEGF receptor protein-tyrosine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients
Cesar Sze-Chuen Wong et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2008)
The role of the VEGF-C/VEGFR-3 axis in cancer progression
J-L Su et al.
BRITISH JOURNAL OF CANCER (2007)
Potential therapeutic strategies for lymphatic metastasis
Bernadette M. M. Zwaans et al.
MICROVASCULAR RESEARCH (2007)
Lymphatic microvessel density as prognostic marker in colorectal cancer
Reda S. Saad et al.
MODERN PATHOLOGY (2006)
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
Marcin Kowanetz et al.
CLINICAL CANCER RESEARCH (2006)
Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage in initiation protein Cdc6 in HL-60 cells
Jin-Long Li et al.
ANTI-CANCER DRUGS (2006)
Mechanisms of lymphangiogenesis: Targets for blocking the metastatic spread of cancer
BK McColl et al.
CURRENT CANCER DRUG TARGETS (2005)
Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells
Yue-Zu Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio
SH Kok et al.
CANCER LETTERS (2005)
Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody
B Pytowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis
DG Jackson
APMIS (2004)
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression
C Scavelli et al.
LEUKEMIA (2004)
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis
JA Nagy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells
YN Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand
F Peng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety
YP Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells
LT Wu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2001)
Share Paper
